BridgeMD
Prevention study for Myopia
Official title Optimizing Light Exposure for Myopia Prevention and Control (LightSPAN)
ClinicalTrials.gov ID: NCT06631339
What this study is testing
- What it's testing
- The goal of this clinical trial is to evaluate whether the optimization of daily exposure to light in primary school children can lead to better myopia prevention and control. The trial also aims to better understand the impact of light exposure on sleep and cognitive performance in children.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 7 to 10. Healthy volunteers may be eligible.
You may be able to join if
- Subject must meet all the below to participate in this study.
- Written Informed Consent form from parent / legal guardian and assent from child subject has been obtained
- Is between 7 to 10 years of age at start of study intervention which is 2 January 2025 or 1 January 2026
- Studying in either Primary 2 or 3 classes of the participating school(s) in academic year 2025 or 2026.
- Presenting visual acuity or best corrected visual acuity (BCVA) better or equal to LogMAR 0.2 (equivalent to Snellen 6/9 or better) in each eye
You likely can't join if
- All people meeting any of the exclusion criteria at baseline will be excluded from participation.
- Previous or ongoing myopia control treatment (including but not limited to orthokeratology, atropine, pirenzepine, myopia control spectacle and...
- Ongoing participation in other myopia prevention and control research trials
- Any systemic or neurologic diseases (e.g. cancer, epilepsy, Kawasaki disease) known to affect eye health or make the participant vulnerable to the...
- Any other conditions precluding adherence to the protocol including unwillingness to refrain from myopia control treatment for the duration of the...
See the full eligibility criteria
- Subject must meet all the below to participate in this study.
- Written Informed Consent form from parent / legal guardian and assent from child subject has been obtained
- Is between 7 to 10 years of age at start of study intervention which is 2 January 2025 or 1 January 2026
- Studying in either Primary 2 or 3 classes of the participating school(s) in academic year 2025 or 2026.
- Presenting visual acuity or best corrected visual acuity (BCVA) better or equal to LogMAR 0.2 (equivalent to Snellen 6/9 or better) in each eye
- Normal Intraocular pressure (not more than 21mmHg)
- No ocular conditions (e.g., optic nerve disease, glaucoma, retinal diseases) except for refractive error.
- No ocular conditions affecting the accuracy of the ophthalmic examinations
- In good general health with no significant systemic diseases that may affect eye health
- All people meeting any of the exclusion criteria at baseline will be excluded from participation.
- Previous or ongoing myopia control treatment (including but not limited to orthokeratology, atropine, pirenzepine, myopia control spectacle and contact lenses, light therapy)
- Ongoing participation in other myopia prevention and control research trials
- Any systemic or neurologic diseases (e.g. cancer, epilepsy, Kawasaki disease) known to affect eye health or make the participant vulnerable to the ophthalmic examinations (e.g., light flash)
- Any other conditions precluding adherence to the protocol including unwillingness to refrain from myopia control treatment for the duration of the study
The study team makes the final eligibility decision.
Where it's taking place
- Singapore, Singapore
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 7 years to 10 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Singapore, Singapore. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.